<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html lang="en" xml:lang="en" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">


<meta name="wpd_version" content="0.2">
<meta name="wpd_baseurl" content="http://aac.asm.org/content/44/8/2093.short">
<meta name="wpd_url" content="http://aac.asm.org/content/44/8/2093.short">
<meta name="wpd_date" content="2013-04-26T21:16Z">
<script async="" src="cb=gapi.loaded_0"></script>
      
      <title>BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available
         Antiretroviral Agents 
      </title>
      <meta name="googlebot" content="NOODP">
      <meta name="googlebot" content="NOODP">
      <meta name="HW.ad-path" content="/cgi/content/abstract/44/8/2093">
      <meta content="/aac/44/8/2093.atom" name="HW.identifier">
      <meta name="DC.Format" content="text/html">
      <meta name="DC.Language" content="en">
      <meta content="BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents" name="DC.Title">
      <meta content="10.1128/AAC.44.8.2093-2099.2000" name="DC.Identifier">
      <meta content="2000-08-01" name="DC.Date">
      <meta content="American Society for Microbiology" name="DC.Publisher">
      <meta content="Brett S. Robinson" name="DC.Contributor">
      <meta content="Keith A. Riccardi" name="DC.Contributor">
      <meta content="Yi-fei Gong" name="DC.Contributor">
      <meta content="Qi Guo" name="DC.Contributor">
      <meta content="David A. Stock" name="DC.Contributor">
      <meta content="Wade S. Blair" name="DC.Contributor">
      <meta content="Brian J. Terry" name="DC.Contributor">
      <meta content="Carol A. Deminie" name="DC.Contributor">
      <meta content="Fred Djang" name="DC.Contributor">
      <meta content="Richard J. Colonno" name="DC.Contributor">
      <meta content="Pin-fang Lin" name="DC.Contributor">
      <meta content="Antimicrobial Agents and Chemotherapy" name="citation_journal_title">
      <meta content="Antimicrob. Agents Chemother." name="citation_journal_abbrev">
      <meta content="0066-4804" name="citation_issn">
      <meta content="1098-6596" name="citation_issn">
      <meta name="citation_author" content="Brett S. Robinson">
      <meta name="citation_author" content="Keith A. Riccardi">
      <meta name="citation_author" content="Yi-fei Gong">
      <meta name="citation_author" content="Qi Guo">
      <meta name="citation_author" content="David A. Stock">
      <meta name="citation_author" content="Wade S. Blair">
      <meta name="citation_author" content="Brian J. Terry">
      <meta name="citation_author" content="Carol A. Deminie">
      <meta name="citation_author" content="Fred Djang">
      <meta name="citation_author" content="Richard J. Colonno">
      <meta name="citation_author" content="Pin-fang Lin">
      <meta content="BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents" name="citation_title">
      <meta content="08/01/2000" name="citation_date">
      <meta content="44" name="citation_volume">
      <meta content="8" name="citation_issue">
      <meta content="2093" name="citation_firstpage">
      <meta content="2099" name="citation_lastpage">
      <meta content="44/8/2093" name="citation_id">
      <meta content="aac;44/8/2093" name="citation_mjid">
      <meta content="10.1128/AAC.44.8.2093-2099.2000" name="citation_doi">
      <meta content="http://aac.asm.org/content/44/8/2093.abstract" name="citation_abstract_html_url">
      <meta content="http://aac.asm.org/content/44/8/2093.full" name="citation_fulltext_html_url">
      <meta content="http://aac.asm.org/content/44/8/2093.full.pdf" name="citation_pdf_url">
      <meta content="http://aac.asm.org/content/44/8/2093" name="citation_public_url">
      <meta content="10898681" name="citation_pmid">
      <meta name="citation_section" content="ANTIVIRAL AGENTS">
      <meta name="robots" content="noarchive">
      <link href="http://aac.asm.org/content/44/8/2086.short" rel="prev">
      <link href="http://aac.asm.org/content/44/8/2100.short" rel="next">
      
      
      
      
      
      
      
      
      
      
      <script type="text/javascript" id="session-d134524195e1">var callbackToken='513D0CDB66FA9F8';</script><script type="text/javascript" src="jquery-min.js"></script><script type="text/javascript" src="hw-shared.js"></script><script type="text/javascript" src="hw-design1.js"></script><script type="text/javascript" src="hw-sheridanpod.js"></script><script type="text/javascript" src="hw-publisher-global.js"></script><script type="text/javascript" src="hw-content.js"></script><script type="text/javascript" src="AccessCheckLib.js"></script><script type="text/javascript" src="executeAccessCheck.js"></script><script type="text/javascript" src="jquery.fancybox-1.3.4.js"></script><script type="text/javascript" src="jquery.easing-1.3.pack.js"></script><script type="text/javascript" src="jquery.mousewheel-3.0.4.pack.js"></script><script type="text/javascript" src="content.jquery.addVariantLink.js"></script><script type="text/javascript" src="hw-col-expand.js"></script><script type="text/javascript" src="hw-publisher-content.js"></script><script type="text/javascript" src="survey.js"></script><script type="text/javascript">

	                
                
        
                   var OAS_sitepage = 'aac.asm.org';
                
    
           
	        </script><script type="text/javascript" src="ads-realmedia.js"></script>
<link rel="stylesheet" type="text/css" href="2093.css" media="all">
</head>
<body>
      <div id="dic_bubble" class="selection_bubble fontSize13 noSelect" style="z-index: 9999; border: 1px solid rgb(74, 174, 222);"></div><div class="hw-gen-page pagetype-content" id="pageid-content" itemscope="itemscope" itemtype="http://schema.org/ScholarlyArticle">
         <div id="header">
            
            <h1><a href="http://www.asm.org/" id="society-link"><span>American Society for Microbiology</span></a><a id="logo" href="http://aac.asm.org/"><span>Antimicrobial Agents and Chemotherapy</span></a></h1>
            
            <p id="skip-link">
               <a href="#content-block">Skip to main page content</a>
               
            </p>
            
            <ul class="button-list header-buttons">
               <li class="first"><a href="http://aac.asm.org/" title="Home"><span>Home</span></a></li>
               <li><a href="http://aac.asm.org/content/current" title="Current Issue"><span>Current Issue</span></a></li>
               <li><a href="http://aac.asm.org/content/by/year" title="Archive"><span>Archive</span></a></li>
               <li><a href="http://journals.asm.org/cgi/alerts/etoc" title="Alerts"><span>Alerts</span></a></li>
               <li><a href="http://www.asm.org/about-asm" title="About ASM"><span>About ASM</span></a></li>
               <li><a href="http://aac.asm.org/site/misc/contact.xhtml" title="Contact us"><span>Contact us</span></a></li>
               <li><a href="http://aac.asm.org/cgi/feedback" title="Tech Support"><span>Tech Support</span></a></li>
               <li class="last"><a href="http://journals.asm.org/" title="Journals."><span>Journals.
                        <span xmlns="" class="red">ASM</span>.org</span></a></li>
            </ul>
            
            
            <div class="header-qs">
               
               <form class="searchbox" action="http://aac.asm.org/search" method="get">
                  <div>
                     <label for="header-qs-input" id="header-qs-search-label">keywords</label>
                     <input style="color: rgb(160, 160, 160);" value="keywords" title="keywords" name="fulltext" id="header-qs-input" type="text"><input name="submit" value="yes" type="hidden"><a href="#" id="hdr-qs-search-a"><label for="header-qs-search" id="header-qs-search-label">GO</label></a><input value="GO" alt="Link: Go" id="header-qs-search-go" src="btn-go.gif" type="image">
                     
                  </div>
                  <div class="adv-search-link"><a href="http://aac.asm.org/search">Advanced »</a></div>
               </form>    
               
            </div>
            
            <div class="header-ac-elements">
               
               <div class="inst-branding">
                  
               </div>
               
               <div id="authstring">
                  
                  
               </div> 
               
               
               <div id="hdr-login">
                  
                  <form action="http://aac.asm.org/login" method="post">
                     <div>
                        <label for="hdr-login-username" id="hdr-login-username-label">User Name</label>
                        <input style="color: rgb(160, 160, 160);" name="username" id="hdr-login-username" type="text">
                        <label for="hdr-login-password" id="hdr-login-password-label">Password</label>
                        <input style="color: rgb(160, 160, 160);" name="code" id="hdr-login-password" type="password">
                        <a href="#" id="hdr-login-signin-label-a"><label for="hdr-login-signin" id="hdr-login-signin-label">

                           Sign In
                           </label></a>
                        <input style="color: rgb(160, 160, 160);" value="http://aac.asm.org/content/44/8/2093.short" name="uri" type="hidden">
                        <input style="color: rgb(160, 160, 160);" alt="sign in" value="
                           Sign In
                           " id="hdr-login-signin" src="login.gif" type="image">
                        
                     </div>
                  </form>
                  
               </div>
               
            </div>
            
            <div class="banner-ads">
               
               <ul>
                  <li class="position-1 no-ad hdr_left"><span>  </span></li>
               </ul>
               
            </div>
            
            <div class="bar">
               
               <div class="bar-inner"></div>
               
            </div>
            
         </div>
         <div id="leaderboard" class="leaderboard-ads">
            
            <ul>
               <li class="position-ad">
                  <script language="JavaScript" type="text/javascript">

                    OAS_AD('Top');
           </script>
                  </li>
            </ul>
            
         </div>
         <div class="leaderboard-clear sb-div"></div>
         <div style="height: auto;" id="content-block"><div class="option-box-docked" style="display: block; left: 665.5px;" id="content-option-box" title="Expand this column"><ul><li id="content-toggle"><a href="#"><span class="descr">Expand</span><span>+</span></a></li></ul></div><div id="print-slug" class="print-only"><span class="jnl-title">Antimicrobial Agents and Chemotherapy</span><span class="jnl-url">aac.asm.org</span><div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">

                              
                              
                              		
                              
                              doi:
                              <span title="10.1128/AAC.44.8.2093-2099.2000" class="slug-doi">10.1128/AAC.44.8.2093-2099.2000
                                 </span>
                              <cite>
                                 	    <abbr title="Antimicrobial Agents and Chemotherapy" class="slug-jnl-abbrev">

                                    Antimicrob. Agents Chemother.</abbr><span class="slug-pub-date" itemprop="datePublished">

                                    	    August 2000 
                                    </span>
                                 	    <span class="slug-vol">

                                    vol. 44 
                                    </span><span class="slug-issue">

                                    no. 8 
                                    </span><span class="slug-pages">

                                    2093-2099
                                    </span>
                                 </cite>
                              
                           </div>
                        </li>
                     </ol>
                  </div></div>
            <div class="article abstract-view" itemprop="articleBody"><span class="highwire-journal-article-marker-start"></span><h1 id="article-title-1" itemprop="headline">BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available
                  Antiretroviral Agents
               </h1>
               <div class="contributors">
                  <ol class="contributor-list" id="contrib-group-1">
                     <li class="contributor" id="contrib-1" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://aac.asm.org/search?author1=Brett+S.+Robinson&amp;sortspec=date&amp;submit=Submit">Brett S. Robinson</a></span><a id="xref-aff-1-1" class="xref-aff" href="#aff-1">1</a>, 
                     </li>
                     <li class="contributor" id="contrib-2" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://aac.asm.org/search?author1=Keith+A.+Riccardi&amp;sortspec=date&amp;submit=Submit">Keith A. Riccardi</a></span><a id="xref-aff-1-2" class="xref-aff" href="#aff-1">1</a>, 
                     </li>
                     <li class="contributor" id="contrib-3" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://aac.asm.org/search?author1=Yi-fei+Gong&amp;sortspec=date&amp;submit=Submit">Yi-fei Gong</a></span><a id="xref-aff-1-3" class="xref-aff" href="#aff-1">1</a>, 
                     </li>
                     <li class="contributor" id="contrib-4" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://aac.asm.org/search?author1=Qi+Guo&amp;sortspec=date&amp;submit=Submit">Qi Guo</a></span><a id="xref-aff-1-4" class="xref-aff" href="#aff-1">1</a>, 
                     </li>
                     <li class="contributor" id="contrib-5" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://aac.asm.org/search?author1=David+A.+Stock&amp;sortspec=date&amp;submit=Submit">David A. Stock</a></span><a id="xref-aff-1-5" class="xref-aff" href="#aff-1">1</a>, 
                     </li>
                     <li class="contributor" id="contrib-6" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://aac.asm.org/search?author1=Wade+S.+Blair&amp;sortspec=date&amp;submit=Submit">Wade S. Blair</a></span><a id="xref-aff-1-6" class="xref-aff" href="#aff-1">1</a>, 
                     </li>
                     <li class="contributor" id="contrib-7" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://aac.asm.org/search?author1=Brian+J.+Terry&amp;sortspec=date&amp;submit=Submit">Brian J. Terry</a></span><a id="xref-aff-1-7" class="xref-aff" href="#aff-1">1</a>, 
                     </li>
                     <li class="contributor" id="contrib-8" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://aac.asm.org/search?author1=Carol+A.+Deminie&amp;sortspec=date&amp;submit=Submit">Carol A. Deminie</a></span><a id="xref-aff-1-8" class="xref-aff" href="#aff-1">1</a>, 
                     </li>
                     <li class="contributor" id="contrib-9" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://aac.asm.org/search?author1=Fred+Djang&amp;sortspec=date&amp;submit=Submit">Fred Djang</a></span><a id="xref-aff-1-9" class="xref-aff" href="#aff-1">1</a>, 
                     </li>
                     <li class="contributor" id="contrib-10" itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person"><span class="name" itemprop="name"><a class="name-search" href="http://aac.asm.org/search?author1=Richard+J.+Colonno&amp;sortspec=date&amp;submit=Submit">Richard J. Colonno</a></span><a id="xref-aff-1-10" class="xref-aff" href="#aff-1">1</a>, and 
                     </li>
                     <li class="last" id="contrib-11"><span class="name"><a class="name-search" href="http://aac.asm.org/search?author1=Pin-fang+Lin&amp;sortspec=date&amp;submit=Submit">Pin-fang Lin</a></span><a id="xref-aff-1-11" class="xref-aff" href="#aff-1">1</a><span class="xref-sep">,</span><a id="xref-fn-1-1" class="xref-fn" href="#fn-1"><sup>*</sup></a></li>
                  </ol><p class="affiliation-list-reveal"><a href="#" class="view-more">+</a> Author Affiliations</p>
                  <ol class="affiliation-list hideaffil">
                     <li class="aff"><a id="aff-1" name="aff-1"></a><address>

                           Department of Virology and Non-Clinical Biostatistics, Bristol-Myers Squibb Company, Wallingford, Connecticut 06492<sup><em>1</em></sup>
                           
                        </address>
                     </li>
                  </ol>
               </div>
               <div class="section abstract" id="abstract-1" itemprop="description">
                  <h2>ABSTRACT</h2>
                  <p id="p-2">BMS-232632 is an azapeptide human immunodeficiency virus type 1 (HIV-1) protease (Prt) inhibitor that exhibits potent anti-HIV
                     activity with a 50% effective concentration (EC<sub>50</sub>) of 2.6 to 5.3 nM and an EC<sub>90</sub> of 9 to 15 nM in cell culture. Proof-of-principle studies indicate that BMS-232632 blocks the cleavage of viral precursor
                     proteins in HIV-infected cells, proving that it functions as an HIV Prt inhibitor. Comparative studies showed that BMS-232632
                     is generally more potent than the five currently approved HIV-1 Prt inhibitors. Furthermore, BMS-232632 is highly selective
                     for HIV-1 Prt and exhibits cytotoxicity only at concentrations 6,500- to 23,000-fold higher than that required for anti-HIV
                     activity. To assess the potential of this inhibitor when used in combination with other antiretrovirals, BMS-232632 was evaluated
                     for anti-HIV activity in two-drug combination studies. Combinations of BMS-232632 with either stavudine, didanosine, lamivudine,
                     zidovudine, nelfinavir, indinavir, ritonavir, saquinavir, or amprenavir in HIV-infected peripheral blood mononuclear cells
                     yielded additive to moderately synergistic antiviral effects. Importantly, combinations of drug pairs did not result in antagonistic
                     anti-HIV activity or enhanced cytotoxic effects at the highest concentrations used for antiviral evaluation. Our results suggest
                     that BMS-232632 may be an effective HIV-1 inhibitor that may be utilized in a variety of different drug combinations.
                  </p>
               </div><div class="emptySection"></div>
               <div class="section fn-group" id="fn-group-1">
                  <h2>FOOTNOTES</h2>
                  <ul>
                     <ul class="history-list">
                        <li xmlns:hwp="http://schema.highwire.org/Journal" class="received" hwp:start="1999-07-16"><span class="received-label">Received </span>16 July 1999.
                        </li>
                        <li xmlns:hwp="http://schema.highwire.org/Journal" class="rev-request" hwp:start="1999-10-13"><span class="rev-request-label">Returned for modification </span>13 October 1999.
                        </li>
                        <li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted" hwp:start="2000-04-07"><span class="accepted-label">Accepted </span>7 April 2000.
                        </li>
                     </ul>
                     <li class="fn-corresp" id="fn-1">
                        <p id="p-1"><a class="rev-xref" href="#xref-fn-1-1">↵</a><span class="fn-label">*</span> Corresponding author. Mailing address: Bristol-Myers Squibb Co., 5 Research Pkwy., Wallingford, CT 06492. Phone: (203) 677-6437.
                           Fax: (203) 677-6088. E-mail: <a href="mailto:linp@bms.com">linp@bms.com</a>.
                        </p>
                     </li>
                  </ul>
               </div>
               <ul class="copyright-statement">
                  <li class="fn" id="copyright-statement-1">Copyright © 2000 American Society for Microbiology</li>
               </ul><span class="highwire-journal-article-marker-end"></span></div>
            <div class="social-bookmarking">
               
               <ul class="social-bookmark-links">
                  <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=CITEULIKE"><img src="citeulike.gif" alt="Add to CiteULike" title="CiteULike"></a><span class="soc-bm-link-text">CiteULike</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=DEL_ICIO_US"><img src="delicious.gif" alt="Add to Delicious" title="Delicious"></a><span class="soc-bm-link-text">Delicious</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-digg"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=DIGG"><img src="digg.gif" alt="Add to Digg" title="Digg"></a><span class="soc-bm-link-text">Digg</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-facebook"><a title="[opens in a new window]" target="_top" href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/short/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=FACEBOOK" class="sb-facebook" rel="external-nw"><img src="facebook.gif" alt="Add to Facebook" title="Facebook"></a><span class="soc-bm-link-text">Facebook</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-googleplus"><div id="___plusone_0" style="text-indent: 0px; margin: 0px; padding: 0px; background: none repeat ; 0% transparent; border-style: none; float: none; line-height: normal; font-size: 1px; vertical-align: baseline; display: inline-block; width: 24px; height: 15px;"><iframe title="+1" data-gapiattached="true" allowtransparency="true" src="2093_1.html" name="I0_1369602979926" id="I0_1369602979926" vspace="0" tabindex="0" style="position: static; top: 0px; width: 24px; margin: 0px; border-style: none; left: 0px; visibility: visible; height: 15px;" marginwidth="0" marginheight="0" hspace="0" frameborder="0" scrolling="no" width="100%"></iframe></div><a style="display: none;" href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="googleplus.jpg" alt="Add to Google+" title="Google+"></a><span class="soc-bm-link-text">Google+</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=MENDELEY"><img src="mendeley.gif" alt="Add to Mendeley" title="Mendeley"></a><span class="soc-bm-link-text">Mendeley</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-reddit"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=REDDIT"><img src="reddit.gif" alt="Add to Reddit" title="Reddit"></a><span class="soc-bm-link-text">Reddit</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-stumbleupon"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=STUMBLEUPON"><img src="stumbleupon.gif" alt="Add to StumbleUpon" title="StumbleUpon"></a><span class="soc-bm-link-text">StumbleUpon</span></li>
                  <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=TWITTER"><img src="twitter.gif" alt="Add to Twitter" title="Twitter"></a><span class="soc-bm-link-text">Twitter</span></li>
               </ul>
               
               <p class="social-bookmarking-help"><a href="http://aac.asm.org/help/social_bookmarks.dtl">What's this?</a></p>
               
            </div><span id="related-urls"></span><div xmlns="http://www.w3.org/1999/xhtml" id="cited-by"><h2>Articles citing this article</h2><ul class="cited-by-list"><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Structural and Thermodynamic Basis of Amprenavir/Darunavir and Atazanavir Resistance in HIV-1 Protease with Mutations at Residue 50 </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">April 2013  </span><span class="cit-vol">87<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">8 </span><span class="cit-pages"><span class="cit-first-page">4176</span><span class="cit-sep">-</span><span class="cit-last-page">4184</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/87/8/4176" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/87/8/4176" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/87/8/4176" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Pharmacodynamic and Antiretroviral Activities of Combination Nanoformulated Antiretrovirals in HIV-1-Infected Human Peripheral Blood Lymphocyte-Reconstituted Mice </span> <cite><abbr title="Journal of Infectious Diseases" class="site-title">The Journal of Infectious Disease</abbr> <span class="cit-print-date">November 2012  </span><span class="cit-vol">206<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">10 </span><span class="cit-pages"><span class="cit-first-page">1577</span><span class="cit-sep">-</span><span class="cit-last-page">1588</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jid.oxfordjournals.org/cgi/content/abstract/206/10/1577" rel="abstract">Abstract</a></li><li><a href="http://jid.oxfordjournals.org/cgi/content/full/206/10/1577" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jid.oxfordjournals.org/cgi/reprint/206/10/1577" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">In Vitro Characterization of GS-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease with a Favorable Resistance Profile </span> <cite><abbr title="Antimicrobial Agents and Chemotherapy" class="site-title">Antimicrob. Agents Chemother.</abbr> <span class="cit-print-date">April 2011  </span><span class="cit-vol">55<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">4 </span><span class="cit-pages"><span class="cit-first-page">1366</span><span class="cit-sep">-</span><span class="cit-last-page">1376</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://aac.asm.org/cgi/content/abstract/55/4/1366" rel="abstract">Abstract</a></li><li><a href="http://aac.asm.org/cgi/content/full/55/4/1366" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://aac.asm.org/cgi/reprint/55/4/1366" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Effect of Low-Dose Omeprazole (20 mg Daily) on the Pharmacokinetics of Multiple-Dose Atazanavir With Ritonavir in Healthy Subjects </span> <cite><abbr title="The Journal of Clinical Pharmacology" class="site-title">J Clin Pharmacol</abbr> <span class="cit-print-date">March 2011  </span><span class="cit-vol">51<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">3 </span><span class="cit-pages"><span class="cit-first-page">368</span><span class="cit-sep">-</span><span class="cit-last-page">377</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jcp.sagepub.com/cgi/content/abstract/51/3/368" rel="abstract">Abstract</a></li><li><a href="http://jcp.sagepub.com/cgi/content/full/51/3/368" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jcp.sagepub.com/cgi/reprint/51/3/368" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Evaluating the Substrate-Envelope Hypothesis: Structural Analysis of Novel HIV-1 Protease Inhibitors Designed To Be Robust against Drug Resistance </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">May 2010  </span><span class="cit-vol">84<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">10 </span><span class="cit-pages"><span class="cit-first-page">5368</span><span class="cit-sep">-</span><span class="cit-last-page">5378</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/84/10/5368" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/84/10/5368" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/84/10/5368" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">X-Ray Crystal Structures of Human Immunodeficiency Virus Type 1 Protease Mutants Complexed with Atazanavir </span> <cite><abbr title="Journal of Virology" class="site-title">J. Virol.</abbr> <span class="cit-print-date">September 2007  </span><span class="cit-vol">81<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">17 </span><span class="cit-pages"><span class="cit-first-page">9525</span><span class="cit-sep">-</span><span class="cit-last-page">9535</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jvi.asm.org/cgi/content/abstract/81/17/9525" rel="abstract">Abstract</a></li><li><a href="http://jvi.asm.org/cgi/content/full/81/17/9525" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jvi.asm.org/cgi/reprint/81/17/9525" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Pharmacokinetics of Saquinavir With Atazanavir or Low-Dose Ritonavir Administered Once Daily (ASPIRE I) or Twice Daily (ASPIRE II) in Seronegative Volunteers </span> <cite><abbr title="The Journal of Clinical Pharmacology" class="site-title">J Clin Pharmacol</abbr> <span class="cit-print-date">February 2007  </span><span class="cit-vol">47<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">2 </span><span class="cit-pages"><span class="cit-first-page">201</span><span class="cit-sep">-</span><span class="cit-last-page">208</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jcp.sagepub.com/cgi/content/abstract/47/2/201" rel="abstract">Abstract</a></li><li><a href="http://jcp.sagepub.com/cgi/content/full/47/2/201" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jcp.sagepub.com/cgi/reprint/47/2/201" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Potencies of Human Immunodeficiency Virus Protease Inhibitors In Vitro against Plasmodium falciparum and In Vivo against Murine Malaria </span> <cite><abbr title="Antimicrobial Agents and Chemotherapy" class="site-title">Antimicrob. Agents Chemother.</abbr> <span class="cit-print-date">February 2006  </span><span class="cit-vol">50<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">2 </span><span class="cit-pages"><span class="cit-first-page">639</span><span class="cit-sep">-</span><span class="cit-last-page">648</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://aac.asm.org/cgi/content/abstract/50/2/639" rel="abstract">Abstract</a></li><li><a href="http://aac.asm.org/cgi/content/full/50/2/639" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://aac.asm.org/cgi/reprint/50/2/639" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy </span> <cite><abbr title="Journal of Antimicrobial Chemotherapy" class="site-title">J Antimicrob Chemother</abbr> <span class="cit-print-date">August 2005  </span><span class="cit-vol">56<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">2 </span><span class="cit-pages"><span class="cit-first-page">380</span><span class="cit-sep">-</span><span class="cit-last-page">387</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jac.oxfordjournals.org/cgi/content/abstract/56/2/380" rel="abstract">Abstract</a></li><li><a href="http://jac.oxfordjournals.org/cgi/content/full/56/2/380" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jac.oxfordjournals.org/cgi/reprint/56/2/380" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">TMC114, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor Active against Protease Inhibitor-Resistant Viruses, Including a Broad Range of Clinical Isolates </span> <cite><abbr title="Antimicrobial Agents and Chemotherapy" class="site-title">Antimicrob. Agents Chemother.</abbr> <span class="cit-print-date">June 2005  </span><span class="cit-vol">49<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">6 </span><span class="cit-pages"><span class="cit-first-page">2314</span><span class="cit-sep">-</span><span class="cit-last-page">2321</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://aac.asm.org/cgi/content/abstract/49/6/2314" rel="abstract">Abstract</a></li><li><a href="http://aac.asm.org/cgi/content/full/49/6/2314" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://aac.asm.org/cgi/reprint/49/6/2314" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO </span> <cite><abbr title="Drug Metabolism and Disposition" class="site-title">Drug Metab. Dispos.</abbr> <span class="cit-print-date">June 2005  </span><span class="cit-vol">33<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">6 </span><span class="cit-pages"><span class="cit-first-page">764</span><span class="cit-sep">-</span><span class="cit-last-page">770</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://dmd.aspetjournals.org/cgi/content/abstract/33/6/764" rel="abstract">Abstract</a></li><li><a href="http://dmd.aspetjournals.org/cgi/content/full/33/6/764" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://dmd.aspetjournals.org/cgi/reprint/33/6/764" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Atazanavir </span> <cite><abbr title="The Annals of Pharmacotherapy" class="site-title">The Annals of Pharmacotherapy</abbr> <span class="cit-print-date">October 2004  </span><span class="cit-vol">38<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">10 </span><span class="cit-pages"><span class="cit-first-page">1664</span><span class="cit-sep">-</span><span class="cit-last-page">1674</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://www.theannals.com/cgi/content/abstract/38/10/1664" rel="abstract">Abstract</a></li><li><a href="http://www.theannals.com/cgi/content/full/38/10/1664" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://www.theannals.com/cgi/reprint/38/10/1664" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Atazanavir: New Option for Treatment of HIV Infection </span> <cite><abbr title="Clinical Infectious Diseases" class="site-title">Clinical Infectious Diseases</abbr> <span class="cit-print-date">June 2004  </span><span class="cit-vol">38<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">11 </span><span class="cit-pages"><span class="cit-first-page">1599</span><span class="cit-sep">-</span><span class="cit-last-page">1604</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://cid.oxfordjournals.org/cgi/content/abstract/38/11/1599" rel="abstract">Abstract</a></li><li><a href="http://cid.oxfordjournals.org/cgi/content/full/38/11/1599" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://cid.oxfordjournals.org/cgi/reprint/38/11/1599" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Identification of I50L as the Signature Atazanavir (ATV)-Resistance Mutation in Treatment-Naive HIV-1-Infected Patients Receiving ATV-Containing Regimens </span> <cite><abbr title="Journal of Infectious Diseases" class="site-title">The Journal of Infectious Disease</abbr> <span class="cit-print-date">May 2004  </span><span class="cit-vol">189<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">10 </span><span class="cit-pages"><span class="cit-first-page">1802</span><span class="cit-sep">-</span><span class="cit-last-page">1810</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://jid.oxfordjournals.org/cgi/content/abstract/189/10/1802" rel="abstract">Abstract</a></li><li><a href="http://jid.oxfordjournals.org/cgi/content/full/189/10/1802" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://jid.oxfordjournals.org/cgi/reprint/189/10/1802" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">New drugs for treating drug resistant HIV-1 </span> <cite><abbr title="Sexually Transmitted Infections" class="site-title">Sex. Transm. Infect.</abbr> <span class="cit-print-date">June 2003  </span><span class="cit-vol">79<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">3 </span><span class="cit-pages"><span class="cit-first-page">176</span><span class="cit-sep">-</span><span class="cit-last-page">178</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://sti.bmjjournals.com/cgi/content/full/79/3/176" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://sti.bmjjournals.com/cgi/reprint/79/3/176" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Activities of Atazanavir (BMS-232632) against a Large Panel of Human Immunodeficiency Virus Type 1 Clinical Isolates Resistant to One or More Approved Protease Inhibitors </span> <cite><abbr title="Antimicrobial Agents and Chemotherapy" class="site-title">Antimicrob. Agents Chemother.</abbr> <span class="cit-print-date">April 2003  </span><span class="cit-vol">47<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">4 </span><span class="cit-pages"><span class="cit-first-page">1324</span><span class="cit-sep">-</span><span class="cit-last-page">1333</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://aac.asm.org/cgi/content/abstract/47/4/1324" rel="abstract">Abstract</a></li><li><a href="http://aac.asm.org/cgi/content/full/47/4/1324" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://aac.asm.org/cgi/reprint/47/4/1324" rel="full-text.pdf">PDF</a></li></ul>  </div> </li><li class="cit"><div class="cit-metadata"><span class="cit-first-element cit-title">Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance </span> <cite><abbr title="Clinical Microbiology Reviews" class="site-title">Clin. Microbiol. Rev.</abbr> <span class="cit-print-date">April 2002  </span><span class="cit-vol">15<span class="cit-sep cit-sep-after-article-vol">:</span></span><span class="cit-issue">2 </span><span class="cit-pages"><span class="cit-first-page">247</span><span class="cit-sep">-</span><span class="cit-last-page">277</span></span></cite>  </div><div class="cit-extra"><ul class="cit-views"><li class="first-item"><a href="http://cmr.asm.org/cgi/content/abstract/15/2/247" rel="abstract">Abstract</a></li><li><a href="http://cmr.asm.org/cgi/content/full/15/2/247" rel="full-text">Full Text</a></li><li class="last-item"><a href="http://cmr.asm.org/cgi/reprint/15/2/247" rel="full-text.pdf">PDF</a></li></ul>  </div> </li></ul></div></div>
         <div style="height: 2841px;" id="col-2">
            
            <div class="article-nav sidebar-nav">
               <a href="http://aac.asm.org/content/44/8/2086.short" title="Previous article" class="previous">« Previous</a><span class="article-nav-sep"> | </span><a href="http://aac.asm.org/content/44/8/2100.short" title="Next article" class="next">Next Article »</a>
               
               <span class="toc-link">
                  				<a href="http://aac.asm.org/content/44/8.toc" title="Table of Contents">Table of Contents</a>
                  			</span>
               
               
            </div>
            <div class="content-box" id="article-cb-main">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>This Article</span></h3>
                  <div class="cb-section cb-slug">
                     <ol>
                        <li>
                           <div id="slugline">

                              
                              
                              		
                              
                              doi:
                              <span title="10.1128/AAC.44.8.2093-2099.2000" class="slug-doi">10.1128/AAC.44.8.2093-2099.2000
                                 </span>
                              <cite>
                                 	    <abbr title="Antimicrobial Agents and Chemotherapy" class="slug-jnl-abbrev">

                                    Antimicrob. Agents Chemother.</abbr><span class="slug-pub-date" itemprop="datePublished">

                                    	    August 2000 
                                    </span>
                                 	    <span class="slug-vol">

                                    vol. 44 
                                    </span><span class="slug-issue">

                                    no. 8 
                                    </span><span class="slug-pages">

                                    2093-2099
                                    </span>
                                 </cite>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section cb-views">
                     <ol>
                        <li class="abstract-view-link primary"><span class="variant-indicator">» <span>Abstract</span></span><span class="viewspecificaccesscheck aac;44/8/2093 abstract"></span></li>
                        <li><a href="http://aac.asm.org/content/44/8/2093.figures-only" rel="view-figures-only">Figures</a><span class="viewspecificaccesscheck aac;44/8/2093 figsonly"></span></li>
                        <li class="notice full-text-view-link primary"><a href="http://aac.asm.org/content/44/8/2093.full" rel="view-full-text">Full Text</a><span class="viewspecificaccesscheck aac;44/8/2093 full"></span></li>
                        <li class="notice full-text-pdf-view-link primary"><a href="http://aac.asm.org/content/44/8/2093.full.pdf+html" rel="view-full-text.pdf">PDF</a><span class="viewspecificaccesscheck aac;44/8/2093 reprint"></span></li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-cat">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Classifications</span></a></h4>
                     <ol>
                        <li>
                           <ul class="subject-headings last-child">
                              <li><a class="tocsection-search" href="http://aac.asm.org/search?tocsectionid=ANTIVIRAL+AGENTS&amp;sortspec=date&amp;submit=Submit">ANTIVIRAL AGENTS</a></li>
                           </ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section collapsible" id="cb-art-svcs">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">-</span> <span>Services</span></a></h4>
                     <ol>
                        <li class="mail-a-friend-link icon-link"><a href="http://aac.asm.org/email?gca=aac;44/8/2093&amp;current-view-path=/content/44/8/2093.short">

                              Email this article to a colleague</a></li>
                        <li class="red"><a href="http://aac.asm.org/search?qbe=aac;44/8/2093&amp;journalcode=all&amp;citation=Robinson%20et%20al.%2044%20%288%29:%202093&amp;submit=yes">Similar articles in ASM journals</a></li>
                        <li class="alert-link icon-link"><a href="http://aac.asm.org/cgi/alerts/ctalert?alertType=citedby&amp;addAlert=cited_by&amp;cited_by_criteria_resid=aac;44/8/2093&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://aac.asm.org/content/44/8/2093.short">Alert me when this article is cited</a></li>
                        <li class="alert-link icon-link"><a href="http://aac.asm.org/cgi/alerts/ctalert?alertType=correction&amp;addAlert=correction&amp;correction_criteria_value=44/8/2093&amp;saveAlert=no&amp;return-type=article&amp;return_url=http://aac.asm.org/content/44/8/2093.short">Alert me if a correction is posted</a></li>
                        <li class="similar-link"><a href="http://aac.asm.org/search?qbe=aac;44/8/2093&amp;citation=Robinson%20et%20al.%2044%20%288%29:%202093&amp;submit=yes">Similar articles in this journal</a></li>
                        <li class="similar-link nodata"><div id="cb-loaded-isi-related-none">No Web of Science related articles</div></li>
                        <li class="similar-link"><a href="http://aac.asm.org/external-ref?access_num=10898681&amp;link_type=MED_NBRS" class="similar-link">Similar articles in PubMed</a></li>
                        <li><a href="http://aac.asm.org/cgi/alerts/etoc">Alert me to new issues of 
                              <em xmlns="">AAC</em>
                              </a></li>
                        <li class="cit-man-link icon-link cite-link"><a href="http://aac.asm.org/citmgr?gca=aac;44/8/2093">Download to citation manager</a></li>
                        <li class="copyright-link icon-link"><a class="request-permissions" href="https://s100.copyright.com/AppDispatchServlet?publisherName=asm&amp;publication=aac&amp;title=BMS-232632,%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents&amp;publicationDate=08/1/2000&amp;author=Brett%20S.%20Robinson,%20Keith%20A.%20Riccardi,%20Yi-fei%20Gong%20et%20al.&amp;startPage=2093&amp;contentID=10.1128/AAC.44.8.2093-2099.2000&amp;orderBeanReset=true&amp;endPage=2099&amp;volumeNum=44&amp;issueNum=8&amp;copyright=American%20Society%20for%20Microbiology" target="_top">Reprints and Permissions</a></li>
                        <li><a href="http://aac.asm.org/site/misc/terms.xhtml">

                              Copyright Information 
                              </a></li>
                        <li><a href="http://www.asmpress.org/" target="_top">

                              Books from ASM Press 
                              </a></li>
                        <li><a href="http://www.microbeworld.org/" target="_top">

                              MicrobeWorld 
                              </a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-cit">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Citing Articles</span></a></h4>
                     <ol style="display: none;">
                        <li class="hw-citing-link"><a href="#cited-by">View citing article information</a></li>
                        <li><a xmlns="http://www.w3.org/1999/xhtml" href="http://aac.asm.org/external-ref?access_num=aac;44/8/2093&amp;link_type=ISI_CITING&amp;external_url=http%3A%2F%2Fgateway.webofknowledge.com%2Fgateway%2FGateway.cgi%3FGWVersion%3D2%26SrcApp%3DPARTNER_APP%26SrcAuth%3Dstanwire%26KeyUT%3D000088308200014%26DestLinkType%3DCitingArticles%26DestApp%3DWOS_CPL%26UsrCustomerID%3D269fc60adb004b0b719031a97aedf5e9">Citing articles via Web of Science (121)</a></li>
                        <li><a href="http://aac.asm.org/external-ref?access_num=http://aac.asm.org/content/44/8/2093.abstract&amp;link_type=GOOGLESCHOLAR">Citing articles via Google Scholar</a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-gs">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Google Scholar</span></a></h4>
                     <ol style="display: none;">
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ARobinson%20author%3AB.S.%22" class="cb-art-gs-auth author-link">Articles by  Robinson, B. S.</a></li>
                        <li class="cb-art-gs-auth author-link"><a href="http://scholar.google.com/scholar?q=%22author%3ALin%20author%3AP.f.%22" class="cb-art-gs-auth author-link">Articles by  Lin, P. f.</a></li>
                        <li class="cb-art-gs-rel similar-link"><a href="http://aac.asm.org/external-ref?access_num=http://aac.asm.org/content/44/8/2093.abstract&amp;link_type=GOOGLESCHOLARRELATED">Search for related content</a></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed" id="cb-art-pm">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>PubMed</span></a></h4>
                     <ol style="display: none;">
                        <li class="cb-art-pm-cite cite-link icon-link"><a href="http://aac.asm.org/external-ref?access_num=10898681&amp;link_type=PUBMED" class="cb-art-pm-cite cite-link icon-link">PubMed citation</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="http://aac.asm.org/external-ref?access_num=Robinson%20BS&amp;link_type=AUTHORSEARCH" class="cb-art-pm-auth author-link">Articles by  Robinson, B. S.</a></li>
                        <li class="cb-art-pm-auth author-link"><a href="http://aac.asm.org/external-ref?access_num=Lin%20Pf&amp;link_type=AUTHORSEARCH" class="cb-art-pm-auth author-link">Articles by  Lin, P. f.</a></li>
                        <li>
                           <ul xmlns="http://www.w3.org/1999/xhtml">
   <li>Pubmed/NCBI databases
      <ul>
         <li><a href="http://aac.asm.org/cgi/external_ref?id=pubmed_pccompound_mesh&amp;type=acheck&amp;target=pccompound&amp;pmid=10898681&amp;link_type=ENTREZLINKS">Compound via MeSH</a></li>
         <li><a href="http://aac.asm.org/cgi/external_ref?id=pubmed_pcsubstance_mesh&amp;type=acheck&amp;target=pcsubstance&amp;pmid=10898681&amp;link_type=ENTREZLINKS">Substance via MeSH</a></li>
      </ul>
   </li>
   <li>Hazardous Substances DB
      <ul>
         <li><a href="http://aac.asm.org/cgi/external_ref?id=HSDB&amp;type=llinks&amp;target=http%3A%2F%2Ftoxnet.nlm.nih.gov%2Fcgi-bin%2Fsis%2Fsearch%2Fr%3Fdbs%2Bhsdb%3A%40term%2B%40rn%2B198904-31-3&amp;pmid=10898681&amp;link_type=ENTREZLINKS">ATAZANAVIR</a></li>
      </ul>
   </li>
</ul>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed collapsed nodata" id="cb-art-rel">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Related Content</span></a></h4>
                     <ol style="display: none;">
                        <li class="nodata"><div id="cb-loaded-related-urls-none">No related web pages</div></li>
                     </ol>
                  </div>
                  <div class="cb-section default-closed soc-links icon-link collapsed" id="cb-art-soc">
                     <h4 class="cb-section-header"><a href="#" class="collapse-toggle"><span class="view-more">+</span> <span>Social Bookmarking</span></a></h4>
                     <ol style="display: none;">
                        <li>
                           <div class="social-bookmarking">
                              
                              <ul class="social-bookmark-links">
                                 <li class="social-bookmarking-item social-bookmarking-item-citeulike"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=CITEULIKE"><img src="citeulike.gif" alt="Add to CiteULike" title="CiteULike"></a><span class="soc-bm-link-text">CiteULike</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-delicious"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=DEL_ICIO_US"><img src="delicious.gif" alt="Add to Delicious" title="Delicious"></a><span class="soc-bm-link-text">Delicious</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-digg"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=DIGG"><img src="digg.gif" alt="Add to Digg" title="Digg"></a><span class="soc-bm-link-text">Digg</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-facebook"><a title="[opens in a new window]" target="_top" href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/short/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=FACEBOOK" class="sb-facebook" rel="external-nw"><img src="facebook.gif" alt="Add to Facebook" title="Facebook"></a><span class="soc-bm-link-text">Facebook</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-googleplus"><div id="___plusone_1" style="text-indent: 0px; margin: 0px; padding: 0px; background: none repeat ; 0% transparent; border-style: none; float: none; line-height: normal; font-size: 1px; vertical-align: baseline; display: inline-block; width: 24px; height: 15px;"><iframe title="+1" data-gapiattached="true" allowtransparency="true" src="2093_2.html" name="I1_1369602979932" id="I1_1369602979932" vspace="0" tabindex="0" style="position: static; top: 0px; width: 24px; margin: 0px; border-style: none; left: 0px; visibility: visible; height: 15px;" marginwidth="0" marginheight="0" hspace="0" frameborder="0" scrolling="no" width="100%"></iframe></div><a style="display: none;" href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=GOOGLEPLUS&amp;log_only=yes"><img src="googleplus.jpg" alt="Add to Google+" title="Google+"></a><span class="soc-bm-link-text">Google+</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-mendeley"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=MENDELEY"><img src="mendeley.gif" alt="Add to Mendeley" title="Mendeley"></a><span class="soc-bm-link-text">Mendeley</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-reddit"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=REDDIT"><img src="reddit.gif" alt="Add to Reddit" title="Reddit"></a><span class="soc-bm-link-text">Reddit</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-stumbleupon"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=STUMBLEUPON"><img src="stumbleupon.gif" alt="Add to StumbleUpon" title="StumbleUpon"></a><span class="soc-bm-link-text">StumbleUpon</span></li>
                                 <li class="social-bookmarking-item social-bookmarking-item-twitter"><a href="http://aac.asm.org/external-ref?tag_url=http://aac.asm.org/cgi/content/long/44/8/2093&amp;title=BMS-232632%2C%20a%20Highly%20Potent%20Human%20Immunodeficiency%20Virus%20Protease%20Inhibitor%20That%20Can%20Be%20Used%20in%20Combination%20with%20Other%20Available%20Antiretroviral%20Agents+--+Robinson%20et%20al.%2044%20%288%29%3A%202093+--+&amp;doi=10.1128/AAC.44.8.2093-2099.2000&amp;link_type=TWITTER"><img src="twitter.gif" alt="Add to Twitter" title="Twitter"></a><span class="soc-bm-link-text">Twitter</span></li>
                              </ul>
                              
                              <p class="social-bookmarking-help"><a href="http://aac.asm.org/help/social_bookmarks.dtl">What's this?</a></p>
                              
                           </div>
                        </li>
                     </ol>
                  </div>
               </div>
            </div>
            
            
            
         </div>
         <div style="height: 2841px;" id="col-3">
            
            <div class="content-box" id="sidebar-current-issue">
               <div class="cb-contents">
                  <h3 class="cb-contents-header"><span>current issue</span></h3>
                  <div class="cb-section">
                     <ol><span><a href="http://aac.asm.org/content/current" rel="current-issue">June 2013, volume 57, issue 6</a></span></ol>
                  </div>
                  <div class="cb-section">
                     <ol>
                        <li>
                           <div class="current-issue"><a href="http://aac.asm.org/content/current" rel="current-issue"><img src="cover_image_archive_default.gif" alt="Current Issue" height="89" width="67"></a></div>
                        </li>
                     </ol>
                  </div>
                  <div class="cb-section sidebar-etoc-link">
                     <ol>
                        <li><a href="http://aac.asm.org/cgi/alerts/etoc">Alert me to new issues of 
                              <em xmlns="">AAC</em>
                              </a></li>
                     </ol>
                  </div>
               </div>
            </div>
            <div id="sidebar-global-nav">
               
               
               <ul class="button-list pub-links">
                  <li class="first"><a href="http://aac.asm.org/site/misc/about.xhtml" title="About "><span>About 
                           <em xmlns="">AAC</em>
                           </span></a></li>
                  <li><a target="_top" href="http://journals.asm.org/subscriptions/" rel="external-nw" title="Subscribers [opens in a new window]"><span>Subscribers</span></a></li>
                  <li><a href="http://aac.asm.org/site/misc/authors.xhtml" title="Authors"><span>Authors</span></a></li>
                  <li><a href="http://aac.asm.org/site/misc/reviewers.xhtml" title="Reviewers"><span>Reviewers</span></a></li>
                  <li><a target="_top" href="http://journals.asm.org/site/misc/addir.xhtml" rel="external-nw" title="Advertisers [opens in a new window]"><span>Advertisers</span></a></li>
                  <li><a target="_top" href="http://www.asm.org/index.php/news-room/whats-new-in-media-information.html" rel="external-nw" title="Inquiries from the Press [opens in a new window]"><span>Inquiries from the Press</span></a></li>
                  <li><a href="http://journals.asm.org/site/misc/reprints.xhtml" title="Permissions &amp; Commercial Reprints"><span>Permissions &amp; Commercial Reprints</span></a></li>
                  <li><a href="http://journals.asm.org/site/misc/index_compliance.xhtml" title="ASM Journals Public Access Policy"><span>ASM Journals Public Access Policy</span></a></li>
                  <li class="last"><a href="http://aac.asm.org/rss" title="
               "><span>
                           
                           <em xmlns="">AAC</em> RSS Feeds</span>
                        
                        <img alt="
                AAC  RSS Feeds" src="icon_rss_tiny.gif"></a>
                     
                     
                     
                  </li>
               </ul>
               	
               <div class="sidebar-icon-group">
                  
                  <a href="http://aac.msubmit.net/cgi-bin/main.plex">
                     <img src="button_submit.gif" class="submit-icon" title="submit">
                     </a>
                  
               </div>
               
            </div>
            <div class="asm-icon">
               <a title="[opens in a new window]" target="_top" href="http://journals.asm.org/" rel="external-nw" class="img"><img src="society_logo.gif" class="publisher-icon" title="Society Logo"></a>
               <a title="[opens in a new window]" target="_top" href="http://highwire.stanford.edu/" rel="external-nw" class="img"><img src="hplogo.gif" class="pub-icon" title="HighWire Press Logo"></a>						
               
            </div>
            <div class="tower-ads">
               
               <ul class="tower-ads">
                  <li class="position-ad">
                     	<script language="JavaScript" type="text/javascript">

	OAS_AD('Right');
	</script>
                     	</li>
               </ul>
               
            </div>
            
            
            
         </div>
         <div id="footer">
            
            <div class="bar">
               	      
               <div class="footer-group footer-col-left">
                  	        
                  <div class="asmjnls">
                     
                     <div class="asmjnls-logo"><a href="http://journals.asm.org/"><img src="asmlogo_footer_clear_s.gif" alt="Journals.ASM.org" border="0" height="40" width="129"></a></div>
                     
                     <div class="asmjnls-location">
                        
                        <p class="addr">1752 N Street N.W. • Washington DC 20036</p>
                        
                        <p class="phone">202.737.3600 • 202.942.9355 fax • journals@asmusa.org</p>
                        
                     </div>   
                     
                  </div>
                  	      
               </div>
               	
               <div class="footer-group footer-col-right">
                  	  
                  <ul class="issns">
                     <li>
                        <span>Print ISSN: </span>
                        <span class="issn">0066-4804</span>
                        
                     </li>
                     <li>
                        <span>Online ISSN: </span>
                        <span class="issn">1098-6596</span>
                        
                     </li>
                  </ul>
                  	
               </div>
               
            </div>
            
            <div class="footer-copyright">
               
               <div class="asmjnls-copy">
                  
                  <p class="copyw">
                     <a href="http://journals.asm.org/site/misc/terms.xhtml">
                        <span class="linkb">Copyright © 2013 </span></a> 
                     by the <a href="http://www.asm.org/">
                        <span class="linkb">American Society for Microbiology.&nbsp;&nbsp;</span>
                        </a>
                     For an alternate route to <span class="lowerasm">AAC</span>.asm.org, visit: 
                     <a href="http://intl-aac.asm.org/">http://intl-<span class="lowerasm">AAC</span>.asm.org</a>&nbsp;&nbsp;|&nbsp; &nbsp; 
                     <a href="http://aac.asm.org/help/using/alternate-route">More Info»</a>
                     
                  </p>
                  
               </div>
               
            </div>
            
            
            <div class="block-2 sb-div"></div>
            
         </div><script type="text/javascript">

        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script src="ga.js" type="text/javascript"></script><script type="text/javascript">

        try {
        var pageTracker = _gat._getTracker("UA-5821458-3");
        pageTracker._trackPageview();
        } catch(err) {}
        </script><script type="text/javascript">

        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
        document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
        </script><script src="ga.js" type="text/javascript"></script><script type="text/javascript">

        try {
        var pageTracker = _gat._getTracker("UA-189672-34");
        pageTracker._setDomainName(".asm.org");
        pageTracker._trackPageview();
        } catch(err) {}
        </script></div>
   
<div id="fancybox-tmp"></div><div id="fancybox-loading"><div></div></div><div id="fancybox-overlay"></div><div id="fancybox-wrap"><div id="fancybox-outer"><div class="fancybox-bg" id="fancybox-bg-n"></div><div class="fancybox-bg" id="fancybox-bg-ne"></div><div class="fancybox-bg" id="fancybox-bg-e"></div><div class="fancybox-bg" id="fancybox-bg-se"></div><div class="fancybox-bg" id="fancybox-bg-s"></div><div class="fancybox-bg" id="fancybox-bg-sw"></div><div class="fancybox-bg" id="fancybox-bg-w"></div><div class="fancybox-bg" id="fancybox-bg-nw"></div><div id="fancybox-content"></div><a id="fancybox-close"></a><div id="fancybox-title"></div><a href="javascript:;" id="fancybox-left"><span class="fancy-ico" id="fancybox-left-ico"></span></a><a href="javascript:;" id="fancybox-right"><span class="fancy-ico" id="fancybox-right-ico"></span></a></div></div></body>
</html>
